Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

56.65
+1.382.50%
Post-market: 56.650.00000.00%16:58 EDT
Volume:2.13M
Turnover:120.38M
Market Cap:10.86B
PE:20.94
High:57.81
Open:55.64
Low:55.64
Close:55.27
Loading ...

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term

Zacks
·
05 May

BioMarin Pharmaceutical (BMRN) Gets a Buy from Truist Financial

TIPRANKS
·
05 May

BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup

Dow Jones
·
03 May

BioMarin's First-Quarter Earnings & Sales Beat Estimates

Zacks
·
03 May

Q1 2025 BioMarin Pharmaceutical Inc Earnings Call

Thomson Reuters StreetEvents
·
02 May

BioMarin Pharmaceutical: Hold Rating Amid Strong Revenue and Cautious Outlook

TIPRANKS
·
02 May

Biomarin Pharmaceutical Inc (BMRN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
02 May

BioMarin Pharmaceutical Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
02 May

BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
02 May

BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue Estimates

Zacks
·
02 May

BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Rise

MT Newswires Live
·
02 May

BioMarin: Q1 Earnings Snapshot

Associated Press Finance
·
02 May

BRIEF-Biomarin Pharmaceutical Q1 EPS USD 0.95

Reuters
·
02 May

Biomarin Pharmaceutical Q1 EPS USD 0.95

THOMSON REUTERS
·
02 May

Biomarin Pharmaceutical - Has Immaterial Exposure to U.S. Tariffs for China, Mexico and Canada

THOMSON REUTERS
·
02 May

Biomarin Reports First Quarter 2025 Results and Reaffirms Full-Year Guidance

THOMSON REUTERS
·
02 May

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 Earnings

StockStory
·
30 Apr

BioMarin Pharmaceutical Inc expected to post earnings of 71 cents a share - Earnings Preview

Reuters
·
30 Apr

BioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside Potential

Insider Monkey
·
29 Apr

2 Cash-Producing Stocks with Exciting Potential and 1 to Question

StockStory
·
28 Apr